BIOMAT Database Logo BIOMAT Database Logo

Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide. 1998

H Ishizuka, and K Konno, and H Naganuma, and K Nishimura, and H Kouzuki, and H Suzuki, and B Stieger, and P J Meier, and Y Sugiyama
Analytical and Metabolic Research Laboratories, Sankyo Co., Ltd., Shinagawa-ku, Tokyo 140, Japan.

The mechanism for hepatic uptake of temocaprilat, an angiotensin-converting enzyme inhibitor that is predominantly excreted into bile was studied using isolated rat hepatocytes and COS-7 cells expressing the organic anion transporting polypeptide (oatp1). The uptake of temocaprilat into isolated rat hepatocytes exhibited saturation with a Km of 20.9 microM and a Vmax of 0.21 nmol/min/mg protein. This uptake was temperature sensitive and was significantly reduced by metabolic inhibitors, a sulfhydryl-modifying reagent and an anion-exchange inhibitor, although the replacement of Na+ with Li+ in the medium did not affect the uptake. [3H]Temocaprilat uptake was inhibited by estradiol-17beta-D-glucuronide and dibromosulphophthalein, typical substrates for the Na+-independent organic anion transporter, in a concentration-dependent manner, whereas excess estradiol-17beta-D-glucuronide did not completely inhibit the uptake. Temocaprilat uptake into COS-7 cells transfected with oatp1 cDNA revealed a concentration-dependency with a Km of 46.7 microM, a value comparable with that obtained in isolated hepatocytes. The contribution of oatp1 to carrier-mediated hepatic uptake of temocaprilat was less than 50% by correcting the uptake clearance with that of estradiol-17beta-D-glucuronide. A good linear correlation was observed for the inhibitory effect of angiotensin-converting enzyme inhibitors (benazeprilat, cilazaprilat, delaprilat and enalaprilat) between isolated hepatocytes and oatp1-expressing cells. These data suggest that oatp1, along with another transporter(s), mediates the uptake of angiotensin-converting enzyme inhibitors into rat hepatocytes.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23
D013448 Sulfobromophthalein A phenolphthalein that is used as a diagnostic aid in hepatic function determination. Bromsulphalein,Bromosulfophthalein,Bromosulphthalein,Bromthalein,Sulfobromophthalein Disodium,Sulfobromophthalein Sodium,Tetrabromsulphthalein,Disodium, Sulfobromophthalein,Sodium, Sulfobromophthalein
D013841 Thiazepines Compounds that are derivatives of THIEPINS, with a nitrogen replacing a carbon in the seven-membered heterocyclic compound. Thiazepine
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

H Ishizuka, and K Konno, and H Naganuma, and K Nishimura, and H Kouzuki, and H Suzuki, and B Stieger, and P J Meier, and Y Sugiyama
Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes.
February 1999, The Journal of pharmacology and experimental therapeutics,
H Ishizuka, and K Konno, and H Naganuma, and K Nishimura, and H Kouzuki, and H Suzuki, and B Stieger, and P J Meier, and Y Sugiyama
Organic anion transporting polypeptide mediates organic anion/HCO3- exchange.
October 1997, The Journal of biological chemistry,
H Ishizuka, and K Konno, and H Naganuma, and K Nishimura, and H Kouzuki, and H Suzuki, and B Stieger, and P J Meier, and Y Sugiyama
Uptake of enalapril and expression of organic anion transporting polypeptide 1 in zonal, isolated rat hepatocytes.
July 2000, Drug metabolism and disposition: the biological fate of chemicals,
H Ishizuka, and K Konno, and H Naganuma, and K Nishimura, and H Kouzuki, and H Suzuki, and B Stieger, and P J Meier, and Y Sugiyama
pH-dependent transport kinetics of the human organic anion-transporting polypeptide 1A2.
April 2020, Drug metabolism and pharmacokinetics,
H Ishizuka, and K Konno, and H Naganuma, and K Nishimura, and H Kouzuki, and H Suzuki, and B Stieger, and P J Meier, and Y Sugiyama
Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III.
January 2016, Xenobiotica; the fate of foreign compounds in biological systems,
H Ishizuka, and K Konno, and H Naganuma, and K Nishimura, and H Kouzuki, and H Suzuki, and B Stieger, and P J Meier, and Y Sugiyama
Functional characterization of the basolateral rat liver organic anion transporting polypeptide.
August 1994, Hepatology (Baltimore, Md.),
H Ishizuka, and K Konno, and H Naganuma, and K Nishimura, and H Kouzuki, and H Suzuki, and B Stieger, and P J Meier, and Y Sugiyama
Quercetin-3-rhamnoglucoside (rutin) stimulates transport of organic anion compounds mediated by organic anion transporting polypeptide 2B1.
April 2014, Biopharmaceutics & drug disposition,
H Ishizuka, and K Konno, and H Naganuma, and K Nishimura, and H Kouzuki, and H Suzuki, and B Stieger, and P J Meier, and Y Sugiyama
Stimulatory effect on the transport mediated by organic anion transporting polypeptide 2B1.
March 2020, Asian journal of pharmaceutical sciences,
H Ishizuka, and K Konno, and H Naganuma, and K Nishimura, and H Kouzuki, and H Suzuki, and B Stieger, and P J Meier, and Y Sugiyama
Pharmacogenetics of the organic anion transporting polypeptide 1A2.
March 2009, Pharmacogenomics,
H Ishizuka, and K Konno, and H Naganuma, and K Nishimura, and H Kouzuki, and H Suzuki, and B Stieger, and P J Meier, and Y Sugiyama
Tissue expression, ontogeny, and inducibility of rat organic anion transporting polypeptide 4.
May 2002, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!